Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2976

TDMS Study 05136-07 Pathology Tables

NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20

                                                           CORE STUDY




       Facility:  Battelle Northwest

       Chemical CAS #:  0000126-99-8

       Lock Date:  05/04/94

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                19           21           23           27                                     
    Natural Death                                      1            1            1            2                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                29           28           26           21                                     
  Other                                                1                                                                            
  Animals Examined Microscopically                    49           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (49)         (49)         (50)         (49)                                   
      Parasite Metazoan                                4 (8%)                    6 (12%)      2 (4%)                                
   Intestine Large, Rectum                            (49)         (49)         (50)         (50)                                   
      Inflammation, Acute                                           1 (2%)                                                          
      Mineralization                                   2 (4%)                                 1 (2%)                                
      Parasite Metazoan                                2 (4%)       5 (10%)      7 (14%)      2 (4%)                                
   Intestine Large, Cecum                             (48)         (49)         (50)         (49)                                   
      Inflammation, Acute                              1 (2%)       1 (2%)                                                          
      Parasite Metazoan                                5 (10%)      4 (8%)       8 (16%)      5 (10%)                               
   Intestine Small, Jejunum                           (49)         (49)         (49)         (48)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
   Intestine Small, Ileum                             (48)         (49)         (49)         (48)                                   
      Parasite Metazoan                                1 (2%)                    1 (2%)                                             
   Liver                                              (49)         (50)         (50)         (50)                                   
      Angiectasis                                      3 (6%)       7 (14%)      5 (10%)      8 (16%)                               
      Basophilic Focus                                39 (80%)     43 (86%)     45 (90%)     44 (88%)                               
      Clear Cell Focus                                15 (31%)     16 (32%)     14 (28%)      6 (12%)                               
      Degeneration, Cystic                                                                    2 (4%)                                
      Degeneration, Fatty                              5 (10%)      5 (10%)      3 (6%)       3 (6%)                                
      Eosinophilic Focus                               2 (4%)                    1 (2%)       2 (4%)                                
      Hepatodiaphragmatic Nodule                       4 (8%)       7 (14%)      9 (18%)      9 (18%)                               
      Mixed Cell Focus                                 7 (14%)      6 (12%)      6 (12%)      9 (18%)                               
      Necrosis                                         1 (2%)       1 (2%)                    2 (4%)                                
      Bile Duct, Hyperplasia                           9 (18%)     10 (20%)     11 (22%)     16 (32%)                               
      Centrilobular, Necrosis                          1 (2%)       3 (6%)       5 (10%)      8 (16%)                               
   Mesentery                                          (5)          (6)          (8)          (11)                                   
      Inflammation, Chronic Active                     1 (20%)                                1 (9%)                                
      Fat, Necrosis                                    4 (80%)      6 (100%)     7 (88%)      9 (82%)                               
   Pancreas                                           (49)         (50)         (50)         (50)                                   
      Atrophy                                         18 (37%)     14 (28%)     17 (34%)      9 (18%)                               
      Basophilic Focus                                 1 (2%)       1 (2%)       1 (2%)       3 (6%)                                
      Hyperplasia                                                   2 (4%)       1 (2%)       2 (4%)                                
      Lipomatosis                                                   1 (2%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Metaplasia, Hepatocyte                                                     1 (2%)                                             
      Artery, Inflammation                                                                    1 (2%)                                
   Salivary Glands                                    (49)         (50)         (50)         (50)                                   
      Atrophy                                                                    1 (2%)       3 (6%)                                
      Basophilic Focus                                                           1 (2%)                                             
   Stomach, Forestomach                               (49)         (50)         (50)         (50)                                   
      Hyperplasia, Squamous                            1 (2%)                    1 (2%)       3 (6%)                                
      Mineralization                                   1 (2%)                                 1 (2%)                                
      Necrosis                                                      2 (4%)       3 (6%)       1 (2%)                                
      Ulcer                                            1 (2%)                    1 (2%)                                             
   Stomach, Glandular                                 (49)         (50)         (50)         (50)                                   
      Mineralization                                   1 (2%)       1 (2%)       4 (8%)       3 (6%)                                
      Necrosis                                                                   1 (2%)                                             
   Tongue                                             (1)          (4)          (5)          (12)                                   
      Hyperplasia, Squamous                            1 (100%)     1 (25%)      1 (20%)      1 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  38 (78%)     38 (76%)     31 (62%)     41 (82%)                               
      Artery, Inflammation, Chronic                    1 (2%)                                 1 (2%)                                
      Atrium, Thrombosis                                            1 (2%)                                                          
      Schwann Cell, Hyperplasia                                                               1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (49)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Hyperplasia                                     23 (47%)     22 (44%)     22 (44%)     20 (40%)                               
      Hypertrophy                                      8 (16%)     10 (20%)      7 (14%)     10 (20%)                               
      Necrosis                                         2 (4%)                    1 (2%)                                             
      Vacuolization Cytoplasmic                        9 (18%)      5 (10%)     10 (20%)      8 (16%)                               
   Adrenal Medulla                                    (49)         (50)         (50)         (50)                                   
      Hyperplasia                                      7 (14%)     11 (22%)      7 (14%)     10 (20%)                               
   Islets, Pancreatic                                 (49)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)       1 (2%)       3 (6%)                                             
   Parathyroid Gland                                  (48)         (50)         (50)         (48)                                   
      Fibrosis                                                      1 (2%)                                                          
      Hyperplasia                                                   2 (4%)                    1 (2%)                                
   Pituitary Gland                                    (48)         (50)         (50)         (50)                                   
      Pars Distalis, Hyperplasia                       9 (19%)      5 (10%)      3 (6%)      10 (20%)                               
   Thyroid Gland                                      (49)         (50)         (50)         (50)                                   
      Fibrosis                                                      1 (2%)                                                          
      C-Cell, Hyperplasia                             38 (78%)     38 (76%)     35 (70%)     28 (56%)                               
      Follicular Cell, Hyperplasia                                                            2 (4%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (46)         (48)         (46)         (46)                                   
      Hyperplasia                                      2 (4%)       1 (2%)       4 (9%)       4 (9%)                                
      Inflammation, Chronic Active                     4 (9%)       4 (8%)       6 (13%)      4 (9%)                                
   Ovary                                              (49)         (50)         (50)         (50)                                   
      Cyst                                             7 (14%)      6 (12%)      1 (2%)       3 (6%)                                
      Inflammation, Granulomatous                      2 (4%)       1 (2%)       1 (2%)                                             
   Uterus                                             (49)         (50)         (50)         (50)                                   
      Hydrometra                                                                 1 (2%)                                             
      Cervix, Hypertrophy                                           1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (50)         (50)         (50)                                   
      Atrophy                                          3 (6%)                                 1 (2%)                                
      Hyperplasia, Histiocytic                                                   2 (4%)                                             
   Lymph Node                                         (1)          (4)          (4)          (5)                                    
      Iliac, Ectasia                                                             1 (25%)      1 (20%)                               
      Renal, Infiltration Cellular, Plasma Cell                     1 (25%)                                                         
   Lymph Node, Mandibular                             (44)         (48)         (37)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
   Spleen                                             (48)         (50)         (50)         (50)                                   
      Accessory Spleen                                              1 (2%)                    1 (2%)                                
      Angiectasis                                                                             1 (2%)                                
      Fibrosis                                         3 (6%)       1 (2%)       3 (6%)       5 (10%)                               
      Hematopoietic Cell Proliferation                 1 (2%)       4 (8%)       4 (8%)       6 (12%)                               
      Hemorrhage                                       4 (8%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (49)         (50)         (50)         (50)                                   
      Galactocele                                      1 (2%)       1 (2%)       2 (4%)                                             
   Skin                                               (49)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                               1 (2%)                                
      Hyperkeratosis                                   1 (2%)                                                                       
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                     3 (6%)       5 (10%)      2 (4%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (50)         (50)         (50)                                   
      Fracture                                                                                1 (2%)                                
      Hyperostosis                                     4 (8%)       5 (10%)      4 (8%)       3 (6%)                                
      Hyperplasia                                                                             1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (49)         (50)         (50)         (50)                                   
      Hemorrhage                                                                 1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (50)         (50)         (50)                                   
      Congestion, Chronic                                           1 (2%)                                                          
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
      Alveolar Epithelium, Hyperplasia                 6 (12%)     22 (44%)     22 (44%)     34 (68%)                               
      Artery, Mediastinum, Inflammation                                                       1 (2%)                                
   Nose                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                        1 (2%)       2 (4%)                                                          
      Thrombosis                                                    1 (2%)       1 (2%)       3 (6%)                                
      Nasolacrimal Duct, Hyperplasia, Squamous                                                1 (2%)                                
      Olfactory Epithelium, Atrophy                                 1 (2%)      40 (80%)     50 (100%)                              
      Olfactory Epithelium, Fibrosis                                                         49 (98%)                               
      Olfactory Epithelium, Hyperplasia, Basal Cell                             17 (34%)     49 (98%)                               
      Olfactory Epithelium, Hyperplasia,                                                                                            
          Adenomatous                                                                        27 (54%)                               
      Olfactory Epithelium, Inflammation, Chronic                                                                                   
          Active                                                                 2 (4%)      33 (66%)                               
      Olfactory Epithelium, Metaplasia                              1 (2%)      35 (70%)     50 (100%)                              
      Olfactory Epithelium, Necrosis                                             8 (16%)     12 (24%)                               
      Olfactory Epithelium, Glands, Atypia Cellular                                           2 (4%)                                
      Turbinate, Fibrosis, Focal                                    1 (2%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (1)          (3)          (2)                                    
      Cataract                                         1 (100%)                  2 (67%)      2 (100%)                              
      Degeneration                                                  1 (100%)                                                        
      Retina, Atrophy                                                            2 (67%)      2 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)         (50)                                   
      Hydronephrosis                                   1 (2%)                                                                       
      Hyperplasia, Oncocytic                                                                  1 (2%)                                
      Infarct                                                       1 (2%)                    1 (2%)                                
      Mineralization                                                                          1 (2%)                                
      Nephropathy                                     43 (88%)     48 (96%)     49 (98%)     49 (98%)                               
      Artery, Inflammation                                                                    1 (2%)                                
      Pelvis, Inflammation, Acute                                                             1 (2%)                                
      Renal Tubule, Hyperplasia                                                  1 (2%)       4 (8%)                                
   Urinary Bladder                                    (49)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia                                       1 (2%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                34           40           41           41                                     
    Natural Death                                      3            1            4            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                13            9            5            4                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (50)         (49)         (48)         (49)                                   
      Mineralization                                   1 (2%)                                                                       
      Parasite Metazoan                                4 (8%)       7 (14%)                   3 (6%)                                
   Intestine Large, Rectum                            (50)         (47)         (50)         (49)                                   
      Mineralization                                                1 (2%)       1 (2%)                                             
      Parasite Metazoan                                2 (4%)       1 (2%)       2 (4%)                                             
   Intestine Large, Cecum                             (48)         (49)         (46)         (48)                                   
      Necrosis                                         1 (2%)                                                                       
      Parasite Metazoan                               10 (21%)      7 (14%)      7 (15%)      6 (13%)                               
   Intestine Small, Duodenum                          (50)         (49)         (49)         (50)                                   
      Necrosis                                                                   1 (2%)                                             
   Liver                                              (50)         (50)         (49)         (50)                                   
      Angiectasis                                      2 (4%)       5 (10%)      6 (12%)      5 (10%)                               
      Basophilic Focus                                16 (32%)     17 (34%)     21 (43%)     13 (26%)                               
      Clear Cell Focus                                 8 (16%)      6 (12%)      3 (6%)       2 (4%)                                
      Degeneration, Cystic                            13 (26%)     18 (36%)     20 (41%)     21 (42%)                               
      Degeneration, Fatty                              3 (6%)       4 (8%)       4 (8%)       3 (6%)                                
      Eosinophilic Focus                                                         3 (6%)       4 (8%)                                
      Hepatodiaphragmatic Nodule                       2 (4%)       1 (2%)       4 (8%)       3 (6%)                                
      Inflammation, Chronic                                         1 (2%)                                                          
      Mixed Cell Focus                                              1 (2%)       2 (4%)       1 (2%)                                
      Necrosis                                                      2 (4%)       1 (2%)       1 (2%)                                
      Regeneration                                     2 (4%)       3 (6%)       3 (6%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Bile Duct, Hyperplasia                          36 (72%)     40 (80%)     35 (71%)     34 (68%)                               
      Centrilobular, Necrosis                         13 (26%)     13 (26%)     13 (27%)      8 (16%)                               
   Mesentery                                          (16)         (13)         (18)         (13)                                   
      Inflammation, Chronic Active                     1 (6%)       1 (8%)                    1 (8%)                                
      Artery, Mineralization                                                     1 (6%)                                             
      Fat, Hemorrhage                                  1 (6%)                                                                       
      Fat, Necrosis                                   15 (94%)     13 (100%)    14 (78%)     11 (85%)                               
   Oral Mucosa                                                     (2)          (1)          (7)                                    
      Pharyngeal, Hyperplasia, Squamous                                                       3 (43%)                               
   Pancreas                                           (50)         (50)         (49)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Atrophy                                         27 (54%)     27 (54%)     30 (61%)     23 (46%)                               
      Basophilic Focus                                 2 (4%)       2 (4%)       2 (4%)       1 (2%)                                
      Hyperplasia                                      7 (14%)      3 (6%)       5 (10%)      1 (2%)                                
      Artery, Inflammation                                                       2 (4%)                                             
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Hyperplasia, Squamous                            2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic Active                                                            5 (10%)                               
      Mineralization                                   1 (2%)       1 (2%)       1 (2%)                                             
      Necrosis                                         2 (4%)       5 (10%)      2 (4%)       3 (6%)                                
      Ulcer                                            1 (2%)       1 (2%)       6 (12%)     11 (22%)                               
   Stomach, Glandular                                 (49)         (50)         (49)         (50)                                   
      Mineralization                                   5 (10%)      5 (10%)      3 (6%)       5 (10%)                               
      Necrosis                                         2 (4%)       2 (4%)       6 (12%)      2 (4%)                                
   Tooth                                                           (2)                                                              
      Developmental Malformation                                    1 (50%)                                                         
      Inflammation, Chronic Active                                  2 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                                                 (3)          (1)                                    
      Aorta, Mineralization                                                      2 (67%)      1 (100%)                              
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  43 (86%)     46 (92%)     39 (78%)     45 (90%)                               
      Artery, Mineralization                                                     2 (4%)                                             
      Atrium, Thrombosis                               1 (2%)       1 (2%)       4 (8%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (49)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Hyperplasia                                     23 (46%)     25 (50%)     26 (53%)     23 (46%)                               
      Hypertrophy                                      1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Necrosis                                                      2 (4%)       1 (2%)       2 (4%)                                
      Vacuolization Cytoplasmic                        1 (2%)       4 (8%)       3 (6%)       2 (4%)                                
   Adrenal Medulla                                    (50)         (50)         (49)         (50)                                   
      Hyperplasia                                     23 (46%)     19 (38%)     19 (39%)     17 (34%)                               
      Necrosis                                                      1 (2%)                                                          
   Islets, Pancreatic                                 (50)         (50)         (49)         (50)                                   
      Hyperplasia                                      3 (6%)       2 (4%)       3 (6%)       3 (6%)                                
   Parathyroid Gland                                  (48)         (49)         (50)         (50)                                   
      Hyperplasia                                      5 (10%)     10 (20%)     19 (38%)     24 (48%)                               
   Pituitary Gland                                    (50)         (49)         (50)         (49)                                   
      Pars Distalis, Cyst                                           1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Hyperplasia                       7 (14%)      4 (8%)       5 (10%)      2 (4%)                                
      Pars Intermedia, Hyperplasia                                  1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (49)         (50)                                   
      C-Cell, Hyperplasia                             34 (68%)     24 (48%)     23 (47%)     28 (56%)                               
      Follicular Cell, Hyperplasia                                  2 (4%)       4 (8%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (1)                                                                           
      Hyperplasia                                      1 (100%)                                                                     
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Granuloma Sperm                                  2 (4%)       3 (6%)       1 (2%)                                             
      Hyperplasia                                                   2 (4%)       6 (12%)      1 (2%)                                
      Necrosis, Fatty                                                            1 (2%)                                             
   Penis                                              (1)          (3)                                                              
      Vein, Fibrosis                                                1 (33%)                                                         
   Preputial Gland                                    (50)         (50)         (48)         (50)                                   
      Hyperplasia                                      4 (8%)       3 (6%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     9 (18%)      6 (12%)      3 (6%)       4 (8%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      7 (14%)      7 (14%)      5 (10%)      4 (8%)                                
      Inflammation, Chronic Active                     2 (4%)       4 (8%)       4 (8%)       5 (10%)                               
      Mineralization                                   1 (2%)                                                                       
   Seminal Vesicle                                    (50)         (50)         (50)         (49)                                   
      Amyloid Deposition                                                         1 (2%)                                             
      Inflammation, Chronic Active                                                            1 (2%)                                
      Mineralization                                                             1 (2%)                                             
   Testes                                             (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)       4 (8%)       4 (8%)       1 (2%)                                
      Hyperplasia                                                   1 (2%)                                                          
      Artery, Inflammation, Chronic Active             2 (4%)       2 (4%)       4 (8%)       3 (6%)                                
      Interstitial Cell, Hyperplasia                  10 (20%)      4 (8%)       9 (18%)      7 (14%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Necrosis                                         1 (2%)                                                                       
   Lymph Node                                         (12)         (18)         (11)         (15)                                   
      Iliac, Ectasia                                                1 (6%)                                                          
      Pancreatic, Hemorrhage                                                     1 (9%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Renal, Ectasia                                                                          1 (7%)                                
      Renal, Hemorrhage                                1 (8%)       2 (11%)      3 (27%)      5 (33%)                               
      Renal, Infiltration Cellular, Plasma Cell                                  1 (9%)                                             
      Renal, Pigmentation                                                                     1 (7%)                                
   Lymph Node, Mandibular                             (47)         (45)         (44)         (49)                                   
      Ectasia                                          1 (2%)                                                                       
      Hemorrhage                                                                 1 (2%)                                             
      Infiltration Cellular, Plasma Cell                            2 (4%)                    1 (2%)                                
   Lymph Node, Mesenteric                             (50)         (50)         (48)         (50)                                   
      Hemorrhage                                                                 1 (2%)                                             
      Infiltration Cellular, Plasma Cell                                                      1 (2%)                                
   Lymph Node, Mediastinal                            (46)         (47)         (48)         (47)                                   
      Hemorrhage                                                                 1 (2%)                                             
   Spleen                                             (50)         (50)         (49)         (50)                                   
      Accessory Spleen                                 2 (4%)       1 (2%)       1 (2%)                                             
      Fibrosis                                        17 (34%)     19 (38%)     17 (35%)     20 (40%)                               
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)       3 (6%)       6 (12%)                               
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Metaplasia, Lipocyte                                          1 (2%)                                                          
      Necrosis                                         1 (2%)       2 (4%)       3 (6%)                                             
      Thrombosis                                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (30)         (23)         (30)         (28)                                   
      Galactocele                                      4 (13%)      3 (13%)      3 (10%)      1 (4%)                                
      Inflammation, Chronic                            1 (3%)                                                                       
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                        1 (2%)                                                                       
      Hyperkeratosis                                                2 (4%)                    1 (2%)                                
      Inflammation, Chronic Active                     3 (6%)       4 (8%)       8 (16%)      5 (10%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                                        4 (8%)       7 (14%)     11 (22%)                               
      Hyperplasia                                                   1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Hydrocephalus                                                                           1 (2%)                                
      Mineralization                                                                          1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Necrosis                                                      1 (2%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (50)         (50)         (50)                                   
      Inflammation, Acute                              1 (2%)                                 1 (2%)                                
   Lung                                               (50)         (50)         (49)         (50)                                   
      Foreign Body                                                                            1 (2%)                                
      Hemorrhage                                       1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Infiltration Cellular                            1 (2%)                                                                       
      Inflammation, Chronic Active                                               1 (2%)       1 (2%)                                
      Metaplasia, Cartilagenous                        1 (2%)                                                                       
      Metaplasia, Osseous                                           1 (2%)                                                          
      Mineralization                                                1 (2%)       1 (2%)       1 (2%)                                
      Thrombosis                                       1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 5 (10%)     16 (32%)     14 (29%)     25 (50%)                               
      Artery, Mediastinum, Mineralization                                        1 (2%)       2 (4%)                                
   Nose                                               (50)         (50)         (49)         (49)                                   
      Cyst                                                                                    1 (2%)                                
      Inflammation, Suppurative                        1 (2%)       1 (2%)       4 (8%)                                             
      Thrombosis                                      10 (20%)      9 (18%)      3 (6%)       2 (4%)                                
      Olfactory Epithelium, Atrophy                    3 (6%)      12 (24%)     46 (94%)     48 (98%)                               
      Olfactory Epithelium, Fibrosis                                                         47 (96%)                               
      Olfactory Epithelium, Hyperplasia, Basal Cell                             38 (78%)     46 (94%)                               
      Olfactory Epithelium, Hyperplasia,                                                                                            
          Adenomatous                                  2 (4%)                    1 (2%)      42 (86%)                               
      Olfactory Epithelium, Inflammation, Chronic                                                                                   
          Active                                                    5 (10%)      9 (18%)     49 (100%)                              
      Olfactory Epithelium, Metaplasia                 6 (12%)      5 (10%)     45 (92%)     48 (98%)                               
      Olfactory Epithelium, Necrosis                               11 (22%)     26 (53%)     19 (39%)                               
      Respiratory Epithelium, Hyperplasia                                                     1 (2%)                                
      Turbinate, Fibrosis, Focal                                                 5 (10%)                                            
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Mineralization                                                             1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                                       (1)                                    
      External Ear, Inflammation, Chronic Active                                              1 (100%)                              
   Eye                                                             (1)          (1)                                                 
      Cataract                                                                   1 (100%)                                           
      Retina, Atrophy                                               1 (100%)     1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05136-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            CHLOROPRENE                                        Date: 09/13/96  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 15:05:20  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      12.8 PPM     32 PPM       80 PPM                                    
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                             3 (6%)       3 (6%)       3 (6%)       5 (10%)                               
      Hyperplasia, Oncocytic                                                                  2 (4%)                                
      Infarct                                                       2 (4%)       2 (4%)                                             
      Mineralization                                   1 (2%)                    2 (4%)       1 (2%)                                
      Nephropathy                                     50 (100%)    50 (100%)    50 (100%)    50 (100%)                              
      Pelvis, Inflammation, Acute                                                             1 (2%)                                
      Renal Tubule, Hyperplasia                        2 (4%)       3 (6%)       6 (12%)      6 (12%)                               
      Transitional Epithelium, Hyperplasia                                                    1 (2%)                                
   Urinary Bladder                                    (50)         (50)         (50)         (49)                                   
      Hemorrhage                                                    1 (2%)                    1 (2%)                                
      Infiltration Cellular                            1 (2%)                                                                       
      Inflammation, Chronic Active                                  2 (4%)       1 (2%)       1 (2%)                                
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------